LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction

By LabMedica International staff writers
Posted on 23 May 2023
Print article
Image: The world`s first fully integrated platform for automated high molecular weight DNA extraction (Photo courtesy of One BioMed)
Image: The world`s first fully integrated platform for automated high molecular weight DNA extraction (Photo courtesy of One BioMed)

Long-read sequencing, a third-generation technology, throws light on certain "blind spots" that short-read sequencing methods cannot detect, such as complex structural variants. However, isolating high-quality, high molecular weight (HMW) DNA, which is crucial for long-read sequencing, can be a formidable task. The majority of commercial extraction methods compromise the quality and length of the extracted DNA due to mechanical processes like centrifugation or vortexing, as well as alcohol precipitation. These methods tend to be labor-intensive. Now, a novel technology is revolutionizing nucleic acid extraction with a gentle, yet rapid chemistry-based method that selectively binds, gently clusters, and purifies intact DNA using controlled fluidics. This unique workflow is also non-volatile and does not require ethanol, ensuring convenient shipping and room-temperature storage.

One BioMed (Singapore) has launched the X8 HMW DNA Cartridge Kits for automated extraction of HMW DNA, specifically designed for long-read sequencing and genome assembly. The X8 HMW DNA Cartridge Kits, driven by the OneTouch Instrument, present the first globally automated platform for HMW DNA extraction from an array of samples including bacteria, plants, cell culture, tissue, and Peripheral Blood Mononuclear Cells (PBMCs). The kits contain all necessary reagents.

The Xceler8 Platform guarantees consistent and reproducible extraction of HMW DNA up to 2 Mb range from diverse sample types across different users. The purified HMW DNA is fit for a variety of downstream applications including long-read sequencing and de novo genome assembly. Thanks to the flexibility of random access, the Xceler8 Solution can run multiple protocols at the same time and efficiently process up to 8 samples within an hour. This fully integrated, plug-and-play automation system is perfect for labs seeking a highly flexible and consistent method of HMW DNA extraction from a wide variety of sample types.

"We are excited to launch the new X8 HMW DNA Cartridge Kit." said Dr.Mi Kyoung Park, Founder & CEO of One BioMed. "This Kit extends the workflow and performance advantages of the novel Xceler8 Technology, enabling scientists to efficiently extract HMW DNA from a variety of samples, for various downstream applications."

Related Links:
One BioMed 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
High Performance Centrifuge
CO336/336R
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.